Ahmad Samir Alfaar

5.3k total citations
52 papers, 431 citations indexed

About

Ahmad Samir Alfaar is a scholar working on Ophthalmology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ahmad Samir Alfaar has authored 52 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 15 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ahmad Samir Alfaar's work include Ocular Oncology and Treatments (13 papers), Glioma Diagnosis and Treatment (7 papers) and Nonmelanoma Skin Cancer Studies (7 papers). Ahmad Samir Alfaar is often cited by papers focused on Ocular Oncology and Treatments (13 papers), Glioma Diagnosis and Treatment (7 papers) and Nonmelanoma Skin Cancer Studies (7 papers). Ahmad Samir Alfaar collaborates with scholars based in Egypt, Germany and United States. Ahmad Samir Alfaar's co-authors include Anas M. Saad, Muneer J. Al‐Husseini, Mohamed M. Gad, Hesham M. Hamoda, Ibrahim Qaddoumi, Mohamed Amgad, Sameera Ezzat, Hala Taha, Matúš Rehák and Mohamed S. Zaghloul and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Ahmad Samir Alfaar

51 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmad Samir Alfaar Egypt 11 128 106 78 70 63 52 431
Tomáš Kepák Czechia 11 93 0.7× 51 0.5× 64 0.8× 39 0.6× 103 1.6× 35 457
Emily K. Tam United States 10 172 1.3× 108 1.0× 51 0.7× 24 0.3× 58 0.9× 20 477
Craig G. Wells United States 8 162 1.3× 365 3.4× 62 0.8× 45 0.6× 95 1.5× 14 590
Sandy Lacombe France 10 145 1.1× 118 1.1× 24 0.3× 177 2.5× 17 0.3× 19 527
Farid Arman United States 10 40 0.3× 44 0.4× 25 0.3× 80 1.1× 50 0.8× 33 329
Hüseyin Aksoy Türkiye 13 52 0.4× 42 0.4× 135 1.7× 32 0.5× 57 0.9× 52 524
Paola Fidani Italy 13 73 0.6× 36 0.3× 42 0.5× 119 1.7× 113 1.8× 23 472
Deborah B. Crom United States 13 134 1.0× 67 0.6× 257 3.3× 84 1.2× 30 0.5× 25 694
Thomas J. Clark United States 10 148 1.2× 24 0.2× 20 0.3× 58 0.8× 91 1.4× 31 620
Sahar Kohanim United States 16 138 1.1× 153 1.4× 122 1.6× 141 2.0× 94 1.5× 36 705

Countries citing papers authored by Ahmad Samir Alfaar

Since Specialization
Citations

This map shows the geographic impact of Ahmad Samir Alfaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmad Samir Alfaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmad Samir Alfaar more than expected).

Fields of papers citing papers by Ahmad Samir Alfaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmad Samir Alfaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmad Samir Alfaar. The network helps show where Ahmad Samir Alfaar may publish in the future.

Co-authorship network of co-authors of Ahmad Samir Alfaar

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmad Samir Alfaar. A scholar is included among the top collaborators of Ahmad Samir Alfaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmad Samir Alfaar. Ahmad Samir Alfaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alfaar, Ahmad Samir, et al.. (2025). Nationwide incidence and survival of retinoblastoma in the USA between 1996 and 2018: a review of 5730 cases. Ophthalmic Genetics. 46(2). 144–153.
2.
Sultan, Iyad, et al.. (2025). Trends in childhood cancer: Incidence and survival analysis over 45 years of SEER data. PLoS ONE. 20(1). e0314592–e0314592. 5 indexed citations
3.
Kakkassery, Vinodh, et al.. (2024). The Epidemiology and Survival Outcomes of Adult Conjunctival Malignancies in Germany: A Decade-Long Population-Based Analysis (2009–2019). Ophthalmic Epidemiology. 32(2). 187–196. 1 indexed citations
4.
Abdelazeem, Basel, et al.. (2022). Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?. Cancer Medicine. 12(5). 6318–6324. 9 indexed citations
5.
Alfaar, Ahmad Samir, Anas M. Saad, Peter Wiedemann, & Matúš Rehák. (2021). The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(5). 1723–1731. 11 indexed citations
6.
Alfaar, Ahmad Samir, et al.. (2020). Uveal melanoma-associated cancers revisited. ESMO Open. 5(6). e000990–e000990. 5 indexed citations
7.
Saad, Anas M., et al.. (2020). Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye. 35(9). 2564–2572. 6 indexed citations
8.
Hammad, Mahmoud, et al.. (2020). Pediatric ependymoma: A single-center experience from a developing country. Indian Journal of Cancer. 58(3). 378–378. 6 indexed citations
9.
Reichhart, Nadine, Ahmad Samir Alfaar, Christophe Roubeix, et al.. (2019). Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. Scientific Reports. 9(1). 2257–2257. 24 indexed citations
10.
Rezk, Mohamed, et al.. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. International Journal of Clinical Oncology. 23(4). 625–633. 8 indexed citations
11.
Alfaar, Ahmad Samir, et al.. (2016). Incidence of orbital, conjunctival and lacrimal gland malignant tumors in USA from Surveillance, Epidemiology and End Results, 1973-2009. International Journal of Ophthalmology. 9(12). 1808–1813. 30 indexed citations
12.
Alfaar, Ahmad Samir, et al.. (2016). Clinical Research Recession: Training Needs Perception Among Medical Students. Journal of Cancer Education. 32(4). 728–733. 3 indexed citations
13.
Alfaar, Ahmad Samir, Mohamed Kamal, Wafaa M. Rashed, et al.. (2016). A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. International Ophthalmology. 37(1). 111–118. 4 indexed citations
14.
Taha, Hala, et al.. (2015). Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. Journal of the Egyptian National Cancer Institute. 27(4). 195–203. 14 indexed citations
15.
Alfaar, Ahmad Samir, et al.. (2015). Childhood Ewing Sarcoma of the Orbit. Journal of Pediatric Hematology/Oncology. 37(6). 433–437. 5 indexed citations
16.
Zaghloul, Mohamed S., et al.. (2015). Bilateral clear cell sarcoma of the kidney. Journal of the Egyptian National Cancer Institute. 27(2). 97–100. 4 indexed citations
17.
Mostafa, Mahmoud, et al.. (2015). Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. Biopreservation and Biobanking. 14(1). 9–16. 6 indexed citations
18.
Alfaar, Ahmad Samir, et al.. (2015). Association between quality of clinical trials and human development index in heart failure using JADAD scale. 1(2). 40–46. 3 indexed citations
19.
Alfaar, Ahmad Samir, et al.. (2014). Orbital tumors in USA: Difference in survival patterns. Cancer Epidemiology. 38(5). 515–522. 12 indexed citations
20.
Amgad, Mohamed & Ahmad Samir Alfaar. (2014). Integrating Web 2.0 in Clinical Research Education in a Developing Country. Journal of Cancer Education. 29(3). 536–540. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomáš Kepák Breakdown of academic impact, for papers by Emily K. Tam Breakdown of academic impact, for papers by Craig G. Wells Breakdown of academic impact, for papers by Sandy Lacombe Breakdown of academic impact, for papers by Farid Arman Breakdown of academic impact, for papers by Hüseyin Aksoy Breakdown of academic impact, for papers by Paola Fidani Breakdown of academic impact, for papers by Deborah B. Crom Breakdown of academic impact, for papers by Thomas J. Clark Breakdown of academic impact, for papers by Sahar Kohanim
Rankless by CCL
2026